
Kevin S. Orwig
Examiner (ID: 15505, Phone: (571)270-5869 , Office: P/1611 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 3991, 1658, 1611 |
| Total Applications | 910 |
| Issued Applications | 256 |
| Pending Applications | 48 |
| Abandoned Applications | 609 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17695875
[patent_doc_number] => 11369576
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Transdermal patch with separated regions for delivery of immunomodulators
[patent_app_type] => utility
[patent_app_number] => 15/865001
[patent_app_country] => US
[patent_app_date] => 2018-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 57
[patent_no_of_words] => 22194
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 408
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15865001
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/865001 | Transdermal patch with separated regions for delivery of immunomodulators | Jan 7, 2018 | Issued |
Array
(
[id] => 14596823
[patent_doc_number] => 10351594
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-16
[patent_title] => Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging
[patent_app_type] => utility
[patent_app_number] => 15/861300
[patent_app_country] => US
[patent_app_date] => 2018-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 18249
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15861300
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/861300 | Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging | Jan 2, 2018 | Issued |
Array
(
[id] => 12675676
[patent_doc_number] => 20180117058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => SKIN-PENETRATING FORMULATION OF TAUROLIDINE
[patent_app_type] => utility
[patent_app_number] => 15/858228
[patent_app_country] => US
[patent_app_date] => 2017-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15858228
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/858228 | SKIN-PENETRATING FORMULATION OF TAUROLIDINE | Dec 28, 2017 | Abandoned |
Array
(
[id] => 15766045
[patent_doc_number] => 20200114040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => ANTIMICROBIAL WOUND DRESSINGS
[patent_app_type] => utility
[patent_app_number] => 16/472144
[patent_app_country] => US
[patent_app_date] => 2017-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16472144
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/472144 | ANTIMICROBIAL WOUND DRESSINGS | Dec 27, 2017 | Abandoned |
Array
(
[id] => 13440615
[patent_doc_number] => 20180271850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => ASSAYS, METHODS AND MEANS
[patent_app_type] => utility
[patent_app_number] => 15/853103
[patent_app_country] => US
[patent_app_date] => 2017-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15853103
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/853103 | ASSAYS, METHODS AND MEANS | Dec 21, 2017 | Abandoned |
Array
(
[id] => 16175540
[patent_doc_number] => 20200222508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => GLUCAGON-LIKE PEPTIDE 1 (GLP-1) RECEPTOR AGONIST COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/471596
[patent_app_country] => US
[patent_app_date] => 2017-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471596
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/471596 | GLUCAGON-LIKE PEPTIDE 1 (GLP-1) RECEPTOR AGONIST COMPOSITIONS | Dec 21, 2017 | Abandoned |
Array
(
[id] => 13440617
[patent_doc_number] => 20180271851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => ASSAYS, METHODS AND MEANS
[patent_app_type] => utility
[patent_app_number] => 15/853174
[patent_app_country] => US
[patent_app_date] => 2017-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15853174
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/853174 | ASSAYS, METHODS AND MEANS | Dec 21, 2017 | Abandoned |
Array
(
[id] => 15114513
[patent_doc_number] => 20190343889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => A METHOD FOR DRYING CELL-FREE TISSUE EXTRACT IN A HYDROGEL COMPRISING NANOFIBRILLAR CELLULOSE AND A DRIED HYDROGEL COMPRISING NANOFIBRILLAR CELLULOSE AND CELL-FREE TISSUE EXTRACT
[patent_app_type] => utility
[patent_app_number] => 16/466772
[patent_app_country] => US
[patent_app_date] => 2017-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16238
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16466772
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/466772 | A METHOD FOR DRYING CELL-FREE TISSUE EXTRACT IN A HYDROGEL COMPRISING NANOFIBRILLAR CELLULOSE AND A DRIED HYDROGEL COMPRISING NANOFIBRILLAR CELLULOSE AND CELL-FREE TISSUE EXTRACT | Dec 14, 2017 | Abandoned |
Array
(
[id] => 12606594
[patent_doc_number] => 20180094028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => ACTIVE PEPTIDE FOR INHIBITING AMPA RECEPTOR AND PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/834026
[patent_app_country] => US
[patent_app_date] => 2017-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15834026
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/834026 | Active peptide for inhibiting AMPA receptor and preparation method and use thereof | Dec 5, 2017 | Issued |
Array
(
[id] => 12904711
[patent_doc_number] => 20180193412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => Method of In Vivo Treatment
[patent_app_type] => utility
[patent_app_number] => 15/833171
[patent_app_country] => US
[patent_app_date] => 2017-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15833171
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/833171 | Method of In Vivo Treatment | Dec 5, 2017 | Abandoned |
Array
(
[id] => 13457779
[patent_doc_number] => 20180280432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => METHODS OF TREATING IRON DEFICIENCY WITH SOLUBLE FERRIC PYROPHOSPHATE
[patent_app_type] => utility
[patent_app_number] => 15/809734
[patent_app_country] => US
[patent_app_date] => 2017-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15809734
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/809734 | METHODS OF TREATING IRON DEFICIENCY WITH SOLUBLE FERRIC PYROPHOSPHATE | Nov 9, 2017 | Abandoned |
Array
(
[id] => 12233152
[patent_doc_number] => 20180066016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'Pharmaceutical Compositions and Therapeutic Methods of Use Comprising Selective Agonists of Melanocortin 1 Receptor'
[patent_app_type] => utility
[patent_app_number] => 15/794301
[patent_app_country] => US
[patent_app_date] => 2017-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11314
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15794301
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/794301 | Method of using pharmaceutical compositions comprising selective peptide-based agonists of melanocortin 1 receptor | Oct 25, 2017 | Issued |
Array
(
[id] => 14649157
[patent_doc_number] => 20190231707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => TRANSDERMAL DRUG DELIVERY DEVICE FOR DELIVERING OPIOIDS
[patent_app_type] => utility
[patent_app_number] => 16/330111
[patent_app_country] => US
[patent_app_date] => 2017-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330111
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/330111 | TRANSDERMAL DRUG DELIVERY DEVICE FOR DELIVERING OPIOIDS | Sep 27, 2017 | Abandoned |
Array
(
[id] => 14435287
[patent_doc_number] => 20190175515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => CHOLESTERYL ESTER VESICLES LOADING PEPTIDES, PROTEINS AND NUCLEIC ACIDS INTO CHYLOMICRONS AND BODY CELLS
[patent_app_type] => utility
[patent_app_number] => 16/327561
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48585
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16327561
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/327561 | CHOLESTERYL ESTER VESICLES LOADING PEPTIDES, PROTEINS AND NUCLEIC ACIDS INTO CHYLOMICRONS AND BODY CELLS | Aug 22, 2017 | Abandoned |
Array
(
[id] => 18517608
[patent_doc_number] => 11707478
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Method for increasing uridine concentration in blood plasma
[patent_app_type] => utility
[patent_app_number] => 16/327741
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10471
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16327741
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/327741 | Method for increasing uridine concentration in blood plasma | Aug 22, 2017 | Issued |
Array
(
[id] => 13714471
[patent_doc_number] => 20170368190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
[patent_app_type] => utility
[patent_app_number] => 15/672802
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 262
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15672802
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/672802 | Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same | Aug 8, 2017 | Issued |
Array
(
[id] => 12975841
[patent_doc_number] => 20170340697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => SELECTIVE NOX-1 INHIBITOR PEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/667737
[patent_app_country] => US
[patent_app_date] => 2017-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15667737
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/667737 | Selective Nox-1 inhibitor peptides and uses thereof | Aug 2, 2017 | Issued |
Array
(
[id] => 14403999
[patent_doc_number] => 20190167843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => NERVE GUIDANCE CONDUITS, METHODS OF PRODUCTION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/322253
[patent_app_country] => US
[patent_app_date] => 2017-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6076
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322253
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/322253 | NERVE GUIDANCE CONDUITS, METHODS OF PRODUCTION AND USES THEREOF | Jul 31, 2017 | Abandoned |
Array
(
[id] => 12232102
[patent_doc_number] => 20180064965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'PEPTIDE FOR PROMOTING HAIR GROWTH'
[patent_app_type] => utility
[patent_app_number] => 15/615211
[patent_app_country] => US
[patent_app_date] => 2017-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 1706
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15615211
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/615211 | Peptide for promoting hair growth | Jun 5, 2017 | Issued |
Array
(
[id] => 13311513
[patent_doc_number] => 20180207293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/604361
[patent_app_country] => US
[patent_app_date] => 2017-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15604361
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/604361 | NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE | May 23, 2017 | Abandoned |